Buchumschlag

NANOG as prognostic factor of prostate cancer course

Summary. The variability of the clinical course of prostate cancer (PC) indicates the need to find factors that could predict the aggressive potential of neoplasms accounting the biological characteristics of tumor cells. In this context, the role of NANOG, a transcription factor involved in maintai...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Datum:	2023
Hauptverfasser:	Zadvornyi, T.V., Lukianova, N.Yu., Borikun, T.V., Vitruk, Yu.V., Stakhovsky, E.O., Chekhun, V.F.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	PH Akademperiodyka 2023
Schlagworte:	cancer stem cells disease course variability microRNA-214 NANOG prostate cancer
Online Zugang:	https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-8
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Experimental Oncology

Institution

Experimental Oncology

Ähnliche Einträge

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
von: Kirkilevsky, S.I., et al.
Veröffentlicht: (2023)

Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
von: Chekhun, V.F., et al.
Veröffentlicht: (2023)

Prepuberal stress and obesity: effects on serum corticosterone, prolactin, testosterone and precancerous prostate lesions in adult rats
von: Herrera-Covarrubias, D., et al.
Veröffentlicht: (2023)

MicroRNAs are a key factor in the globalization of tumor-host relationships
von: Chekhun, V.F.
Veröffentlicht: (2023)

Expression pattern of genes associated with tumor microenvironment in prostate cancer
von: Gerashchenko, G.V., et al.
Veröffentlicht: (2018)

Integral characteristic of the immune system state predicts breast cancer outcome
von: Stakheyeva, M., et al.
Veröffentlicht: (2023)

Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
von: Kovalev, A.A., et al.
Veröffentlicht: (2013)

Prognostic factors in metastatic gastric carcinoma
von: Ben Kridis, W., et al.
Veröffentlicht: (2023)

Human microbiota and effectiveness of cancer chemotherapy
von: Shvets, Yu.V., et al.
Veröffentlicht: (2023)

Incidence and long-term effects of treatment of malignant germ cell neoplasms in Ukraine
von: Fedorenko, Z.P., et al.
Veröffentlicht: (2023)

Specialized care provided to patients with rectal cancer in Kyiv city
von: Kliusov, O.M.
Veröffentlicht: (2023)

International scientific conference “Tumor and host: novel aspects of old problem”
Veröffentlicht: (2023)

Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
von: Yalcin, B.
Veröffentlicht: (2013)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
von: Akyurek, S., et al.
Veröffentlicht: (2013)

A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer
von: Yazici, O., et al.
Veröffentlicht: (2013)

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
von: Lyalkin, S.A., et al.
Veröffentlicht: (2023)

Expression of miRNA-126, -205 and -214 in benign and malignant neoplasms of the prostate gland: possible diagnostic and prognostic significance
von: T. V. Zadvornyi, et al.
Veröffentlicht: (2019)

DNA oxidation in patients with metastastic colorectal cancer: clinical significance of 8-hydroxy-deoxyguanosine as an independent prognostic factor
von: Burlaka, A.A., et al.
Veröffentlicht: (2023)

Inducible dominant negative ErbB2 rat spermatogonial line for generation of transgenic rat model and dissecting ERBB2 tyrosine kinase mediated pathways
von: Syvyk, A.E., et al.
Veröffentlicht: (2023)

MiR-205-5P AS POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
von: Babu, S., et al.
Veröffentlicht: (2023)

A case of synchronous bilateral calyx urothelial carcinoma: combined treatment approach
von: Semko, S., et al.
Veröffentlicht: (2023)

Comparative evaluation of purine dysmetabolism in gastric and pulmonary adenocarcinomas
von: Dumanskiy, Y.V., et al.
Veröffentlicht: (2023)

Clinical significance of serum caveolin-1 levels in gastric cancer patients
von: Tas, F., et al.
Veröffentlicht: (2018)

Association between XPO5 rs11077 polymorphism and cancer susceptibility: a meta-analysis of 7284 cases and 8511 controls
von: Moazeni-Roodi, A., et al.
Veröffentlicht: (2023)

Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
von: Buchynska, L.G., et al.
Veröffentlicht: (2023)

Non-linear dynamics theory and malignant melanoma
von: Orel, V.E., et al.
Veröffentlicht: (2023)

FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
von: Arabpour, F., et al.
Veröffentlicht: (2018)

Expression profiling of plac1 in murine cancer cell lines
von: Mahmoudian, J., et al.
Veröffentlicht: (2023)

Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin
von: Lamdan, H., et al.
Veröffentlicht: (2023)

Antiproliferative and apoptotic effects of anti-human HB-EGF neutralizing polyclonal antibodies in vitro
von: Siromolot, A.A., et al.
Veröffentlicht: (2023)

BER gene polymorphisms associated with key molecular events in bladder cancer
von: Smal, M.P., et al.
Veröffentlicht: (2018)

FUT3 expression in human breast cancer cells under hypoxia and serum deprivation
von: Albuquerque, A.P.B., et al.
Veröffentlicht: (2023)

Deletions in metastatic colorectal cancer with chromothripsis
von: Skuja, E., et al.
Veröffentlicht: (2023)

Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival
von: Korovin, S., et al.
Veröffentlicht: (2023)

The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
von: Dumanskiy, Y.V., et al.
Veröffentlicht: (2023)

Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
von: Burlaka, A.P., et al.
Veröffentlicht: (2023)

ФЕНОМЕН «COST DISEASE» СЕКТОРУ КРЕАТИВНИХ ІНДУСТРІЙ УКРАЇНИ
von: Kirzhetska, Mariia, et al.
Veröffentlicht: (2021)

Initial Scientific Meeting of the partner’s organizations Molecular Events in Cancer and Neurodegenerative Diseases
Veröffentlicht: (2012)